BioCryst Pharmaceuticals
BCRX
$4.16
Share price
0.00%
Change (1 day)
-44.75%
Change (1 year)
Categories
BioCryst Pharmaceuticals (BCRX) - Net assets
Net assets on the balance sheet as of December 2023 : -$0.46 B
According to BioCryst Pharmaceuticals
's latest financial reports the company has -$0.46 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
BioCryst Pharmaceuticals - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-0.46 B | 54.63% |
| 2022-12-31 | $-0.3 B | 175.36% |
| 2021-12-31 | $-0.11 B | 455.43% |
| 2020-12-31 | $-19.27 M | -150.36% |
| 2019-12-31 | $38.25 M | -22.31% |
| 2018-12-31 | $49.23 M | -41.22% |
| 2017-12-31 | $83.76 M | 5208.43% |
| 2016-12-31 | $1.57 M | -96.69% |
| 2015-12-31 | $47.72 M | -36.9% |
| 2014-12-31 | $75.63 M | -6817.14% |
| 2013-12-31 | $-1.13 M | 148.02% |
| 2012-12-31 | $-0.46 M | -103.07% |
| 2011-12-31 | $14.8 M | -77.4% |
| 2010-12-31 | $65.5 M | -24.07% |
| 2009-12-31 | $86.26 M | 85.81% |
| 2008-12-31 | $46.42 M | -28.47% |
| 2007-12-31 | $64.9 M | 206.81% |
| 2006-12-31 | $21.15 M | -63.8% |
| 2005-12-31 | $58.44 M | 99.22% |
| 2004-12-31 | $29.33 M | 3.12% |
| 2003-12-31 | $28.44 M | -29.11% |
| 2002-12-31 | $40.12 M | -29.37% |
| 2001-12-31 | $56.81 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $22.74 B | -5,093.99% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.28 B | -3,675.63% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $0.85 B | -288.65% | 🇺🇸 USA |
 Repligen
RGEN | $1.97 B | -532.73% | 🇺🇸 USA |
 Novavax NVAX | -$0.72 B | 57.38% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.42 B | -194.21% | 🇺🇸 USA |
 NanoViricides NNVC | $12.45 M | -102.73% | 🇺🇸 USA |
 Cel-Sci
CVM | $12.65 M | -102.78% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.64 B | -242.54% | 🇺🇸 USA |